Cargando…

Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview

The disadvantages that come with traditional cancer treatments, such as chemotherapy and radiotherapy, generated a research shift toward nanotechnology. However, even with the important advancements regarding cancer therapy, there are still serious stepping stones that need to be addressed. The use...

Descripción completa

Detalles Bibliográficos
Autores principales: Lungu, Iulia Ioana, Grumezescu, Alexandru Mihai, Volceanov, Adrian, Andronescu, Ecaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804091/
https://www.ncbi.nlm.nih.gov/pubmed/31574993
http://dx.doi.org/10.3390/molecules24193547
_version_ 1783461102340800512
author Lungu, Iulia Ioana
Grumezescu, Alexandru Mihai
Volceanov, Adrian
Andronescu, Ecaterina
author_facet Lungu, Iulia Ioana
Grumezescu, Alexandru Mihai
Volceanov, Adrian
Andronescu, Ecaterina
author_sort Lungu, Iulia Ioana
collection PubMed
description The disadvantages that come with traditional cancer treatments, such as chemotherapy and radiotherapy, generated a research shift toward nanotechnology. However, even with the important advancements regarding cancer therapy, there are still serious stepping stones that need to be addressed. The use of both nanotechnology and nanomedicine has generated significant improvements in nano-sized materials development and their use as therapeutic, diagnosis, and imaging agents. The biological barriers that come from the healthy body, as well from the tumorous sites, are important parameters that need to be taken into consideration when designing drug delivery systems. There are several aspects of extreme importance such as the tumor microenvironment and vasculature, the reticuloendothelial system, the blood–brain barrier, the blood–tumor barrier, and the renal system. In order to achieve an effective system for cancer therapy, several characteristics of the nanoparticles have been outlined. Moreover, this review has also focused on the different types of nanoparticles that have been studied over the years as potential candidates for cancer therapy.
format Online
Article
Text
id pubmed-6804091
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68040912019-11-18 Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview Lungu, Iulia Ioana Grumezescu, Alexandru Mihai Volceanov, Adrian Andronescu, Ecaterina Molecules Review The disadvantages that come with traditional cancer treatments, such as chemotherapy and radiotherapy, generated a research shift toward nanotechnology. However, even with the important advancements regarding cancer therapy, there are still serious stepping stones that need to be addressed. The use of both nanotechnology and nanomedicine has generated significant improvements in nano-sized materials development and their use as therapeutic, diagnosis, and imaging agents. The biological barriers that come from the healthy body, as well from the tumorous sites, are important parameters that need to be taken into consideration when designing drug delivery systems. There are several aspects of extreme importance such as the tumor microenvironment and vasculature, the reticuloendothelial system, the blood–brain barrier, the blood–tumor barrier, and the renal system. In order to achieve an effective system for cancer therapy, several characteristics of the nanoparticles have been outlined. Moreover, this review has also focused on the different types of nanoparticles that have been studied over the years as potential candidates for cancer therapy. MDPI 2019-09-30 /pmc/articles/PMC6804091/ /pubmed/31574993 http://dx.doi.org/10.3390/molecules24193547 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lungu, Iulia Ioana
Grumezescu, Alexandru Mihai
Volceanov, Adrian
Andronescu, Ecaterina
Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
title Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
title_full Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
title_fullStr Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
title_full_unstemmed Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
title_short Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
title_sort nanobiomaterials used in cancer therapy: an up-to-date overview
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804091/
https://www.ncbi.nlm.nih.gov/pubmed/31574993
http://dx.doi.org/10.3390/molecules24193547
work_keys_str_mv AT lunguiuliaioana nanobiomaterialsusedincancertherapyanuptodateoverview
AT grumezescualexandrumihai nanobiomaterialsusedincancertherapyanuptodateoverview
AT volceanovadrian nanobiomaterialsusedincancertherapyanuptodateoverview
AT andronescuecaterina nanobiomaterialsusedincancertherapyanuptodateoverview